Literature DB >> 10053019

Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees.

E W Daw1, S C Heath, E M Wijsman.   

Abstract

It is usually difficult to localize genes that cause diseases with late ages at onset. These diseases frequently exhibit complex modes of inheritance, and only recent generations are available to be genotyped and phenotyped. In this situation, multipoint analysis using traditional exact linkage analysis methods, with many markers and full pedigree information, is a computationally intractable problem. Fortunately, Monte Carlo Markov chain sampling provides a tool to address this issue. By treating age at onset as a right-censored quantitative trait, we expand the methods used by Heath (1997) and illustrate them using an Alzheimer disease (AD) data set. This approach estimates the number, sizes, allele frequencies, and positions of quantitative trait loci (QTLs). In this simultaneous multipoint linkage and segregation analysis method, the QTLs are assumed to be diallelic and to interact additively. In the AD data set, we were able to localize correctly, quickly, and accurately two known genes, despite the existence of substantial genetic heterogeneity, thus demonstrating the great promise of these methods for the dissection of late-onset oligogenic diseases.

Entities:  

Mesh:

Year:  1999        PMID: 10053019      PMCID: PMC1377802          DOI: 10.1086/302276

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  A Monte Carlo method for combined segregation and linkage analysis.

Authors:  S W Guo; E A Thompson
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

2.  Adequacy of single-locus approximations for linkage analyses of oligogenic traits.

Authors:  V J Vieland; S E Hodge; D A Greenberg
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

3.  Linkage analysis of two-locus diseases under single-locus and two-locus analysis models.

Authors:  V Vieland; D A Greenberg; S E Hodge; J Ott
Journal:  Cytogenet Cell Genet       Date:  1992

4.  Linkage analysis under "random" and "genetic" reduced penetrance.

Authors:  D A Greenberg; S E Hodge
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

5.  Effects of misspecifying genetic parameters in lod score analysis.

Authors:  F Clerget-Darpoux; C Bonaïti-Pellié; J Hochez
Journal:  Biometrics       Date:  1986-06       Impact factor: 2.571

6.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

7.  Bayesian inference in multipoint gene mapping.

Authors:  D A Stephens; A F Smith
Journal:  Ann Hum Genet       Date:  1993-01       Impact factor: 1.670

8.  The investigation of linkage between a quantitative trait and a marker locus.

Authors:  J K Haseman; R C Elston
Journal:  Behav Genet       Date:  1972-03       Impact factor: 2.805

9.  Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene.

Authors:  P Poorkaj; V Sharma; L Anderson; E Nemens; M E Alonso; H Orr; J White; L Heston; T D Bird; G D Schellenberg
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

10.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

Authors:  G D Schellenberg; T D Bird; E M Wijsman; H T Orr; L Anderson; E Nemens; J A White; L Bonnycastle; J L Weber; M E Alonso
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

View more
  44 in total

1.  Searching for alcoholism susceptibility genes using Markov chain Monte Carlo methods.

Authors:  S M Leal; S C Heath
Journal:  Genet Epidemiol       Date:  1999       Impact factor: 2.135

2.  Performance of Markov chain-Monte Carlo approaches for mapping genes in oligogenic models with an unknown number of loci.

Authors:  J K Lee; D C Thomas
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.025

3.  An additive genetic gamma frailty model for linkage analysis of diseases with variable age of onset using nuclear families.

Authors:  Hongzhe Li
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

4.  Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.

Authors:  France Gagnon; Gail P Jarvik; Arno G Motulsky; Samir S Deeb; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2003-08-29       Impact factor: 4.132

5.  Bayesian model choice and search strategies for mapping interacting quantitative trait Loci.

Authors:  Nengjun Yi; Shizhong Xu; David B Allison
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

Review 6.  Joint oligogenic segregation and linkage analysis using bayesian Markov chain Monte Carlo methods.

Authors:  Ellen M Wijsman; Dongmei Yu
Journal:  Mol Biotechnol       Date:  2004-11       Impact factor: 2.695

7.  Estimation and visualization of identity-by-descent within pedigrees simplifies interpretation of complex trait analysis.

Authors:  Elizabeth E Marchani; Ellen M Wijsman
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

8.  Genome-scan for IQ discrepancy in autism: evidence for loci on chromosomes 10 and 16.

Authors:  Nicola H Chapman; Annette Estes; Jeff Munson; Raphael Bernier; Sara J Webb; Joseph H Rothstein; Nancy J Minshew; Geraldine Dawson; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Hum Genet       Date:  2010-10-21       Impact factor: 4.132

9.  Modifier locus of the skeletal muscle involvement in Emery-Dreifuss muscular dystrophy.

Authors:  B Granger; L Gueneau; V Drouin-Garraud; V Pedergnana; F Gagnon; R Ben Yaou; S Tezenas du Montcel; G Bonne
Journal:  Hum Genet       Date:  2010-11-10       Impact factor: 4.132

10.  The number of trait loci in late-onset Alzheimer disease.

Authors:  E W Daw; H Payami; E J Nemens; D Nochlin; T D Bird; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.